Cohort as Part of Undergraduate Medical Studies at the University of Sherbrooke
Launched by UNIVERSITÉ DE SHERBROOKE · Apr 24, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial at the University of Sherbrooke focuses on understanding public health issues in Quebec, particularly how COVID-19 has affected different communities. The goal is to train third-year medical students to conduct research by gathering important information through telephone interviews with people in various regions of Quebec. Each year, researchers will suggest different health topics for the students to explore, helping to create a clearer picture of public health needs in the province.
To participate in this study, you need to meet a few criteria. You must have been diagnosed with COVID-19 between November 2020 and May 2021 and be a resident of Quebec. Unfortunately, if you're not feeling well or unable to participate, you won't be included in this study. If you're eligible, you can expect to receive a phone call from a medical student who will ask you questions related to your health and experiences during your recovery. Your insights will contribute to better planning and understanding of health services in your community.
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • Participants will have been diagnosed with covid-19 between November 2020 and May 2021;
- • Place of residence: province of Quebec.
- Exclusion criteria :
- • - Unfit adults.
About Université De Sherbrooke
The Université de Sherbrooke is a leading research institution in Canada, renowned for its commitment to advancing knowledge and innovation in various fields, including health sciences. With a focus on interdisciplinary collaboration, the university actively engages in clinical trials to explore new therapeutic interventions and improve patient care. Its research team comprises experienced professionals dedicated to ensuring the highest ethical standards and scientific rigor in clinical research. The Université de Sherbrooke strives to translate research findings into practical solutions that enhance health outcomes and contribute to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sherbrooke, Quebec, Canada
Patients applied
Trial Officials
Paul Farand, MD MSc
Principal Investigator
Université de Sherbrooke
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials